CBX4 and hepatocellular carcinoma: The results of the current study have showed that the relative expression level of lncRNAs (RAMS11, LINC01564), CBX4, and TOP2A were upregulated in CHC patients and more in CHC patients with HCC, suggesting a promising non-invasive diagnostic role of these markers for HCC especially TOP2A.